Human Biome S.A. Explores U.S. Market Expansion at the 2026 SelectUSA Investment Summit

As part of our ongoing commitment to global growth and commercialization, Human Biome S.A. is excited to announce our participation in the prestigious SelectUSA Investment Summit 2026, held in the Washington, D.C. area.

Organized by the U.S. Department of Commerce, SelectUSA is the highest-profile event dedicated to facilitating foreign direct investment (FDI) and business expansion into the United States. Representing Human Biome S.A., our CEO, prof. Jarosław Biliński MD, joined a select delegation of business leaders to explore strategic avenues for bringing our innovative biotherapeutic pipeline to the American healthcare market.

Mapping Out the American Frontier for Microbiome Therapeutics

The multi-day summit brought together thousands of attendees, including international business executives, industry experts, and government officials from all 50 U.S. states. For Human Biome S.A., the summit provided an invaluable platform to lay the groundwork for future international partnerships and regulatory pathways.

Key takeaways from the summit included:

• Strategic Networking: High-level discussions with U.S. economic development organizations, investors, and legal experts specializing in biotech market entry.

• FDI Insights: Gaining actionable intelligence on regional biotechnology clusters, workforce availability, and U.S. federal and state incentives designed for scaling advanced medical technologies.

• Strategic Partnerships: Deepening institutional ties to support our future clinical and commercial footprint in North America.

Celebrating Historic Milestones

Beyond the business roundtables, the trip featured a monumental cultural highlight. Prof. Biliński had the honor of representing Human Biome S.A. at the spectacular gala ball celebrating the 250th Anniversary of the United States, a historic milestone marking America’s enduring legacy of innovation and opportunity.

A Note of Appreciation

Human Biome S.A. extends its sincere gratitude to the U.S. Embassy in Warsaw and the Polish Investment and Trade Agency (PAIH) for the invitation, immaculate organization, and warm welcome throughout the summit. Their continued support is instrumental as we look to build a bridge between European scientific excellence and global markets.

May, 2026